SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-038556
Filing Date
2020-02-14
Accepted
2020-02-14 17:04:15
Documents
23
Period of Report
2020-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889444d8k.htm   iXBRL 8-K 52893
2 EX-4.1 d889444dex41.htm EX-4.1 640415
3 EX-99.1 d889444dex991.htm EX-99.1 188199
4 EX-99.2 d889444dex992.htm EX-99.2 205040
5 EX-99.3 d889444dex993.htm EX-99.3 16892
9 GRAPHIC g889444g0213101822258.jpg GRAPHIC 3544
10 GRAPHIC g889444im70.jpg GRAPHIC 3591
11 GRAPHIC g889444im71.jpg GRAPHIC 4708
12 GRAPHIC g889444im72.jpg GRAPHIC 4462
13 GRAPHIC g889444im73.jpg GRAPHIC 5104
14 GRAPHIC g889444im75.jpg GRAPHIC 4582
15 GRAPHIC g889444im76.jpg GRAPHIC 5827
  Complete submission text file 0001193125-20-038556.txt   1497259

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rvnc-20200211.xsd EX-101.SCH 3067
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvnc-20200211_lab.xml EX-101.LAB 17374
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvnc-20200211_pre.xml EX-101.PRE 10951
21 EXTRACTED XBRL INSTANCE DOCUMENT d889444d8k_htm.xml XML 3238
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 20621679
SIC: 2834 Pharmaceutical Preparations